Amponsah-Offeh, M.* ; Diaba-Nuhoho, P.* ; Speier, S. ; Morawietz, H.*
Oxidative stress, antioxidants and hypertension.
Antioxidants 12:22 (2023)
As a major cause of morbidity and mortality globally, hypertension remains a serious threat to global public health. Despite the availability of many antihypertensive medications, several hypertensive individuals are resistant to standard treatments, and are unable to control their blood pressure. Regulation of the renin-angiotensin-aldosterone system (RAAS) controlling blood pressure, activation of the immune system triggering inflammation and production of reactive oxygen species, leading to oxidative stress and redox-sensitive signaling, have been implicated in the pathogenesis of hypertension. Thus, besides standard antihypertensive medications, which lower arterial pressure, antioxidant medications were tested to improve antihypertensive treatment. We review and discuss the role of oxidative stress in the pathophysiology of hypertension and the potential use of antioxidants in the management of hypertension and its associated organ damage.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Antihypertensive Therapy ; Antioxidants ; Cardiovascular Diseases ; Hypertension ; Oxidative Stress ; Reactive Oxygen Species; Alpha-lipoic Acid; Reduces Blood-pressure; Improves Endothelial Function; Salt-induced Hypertension; Dietary Vitamin-e; Supplementation Attenuates Hypertension; Rostral Ventrolateral Medulla; Fructose-induced Hypertension; N-acetylcysteine Treatment; Renin-angiotensin System
Keywords plus
Language
english
Publication Year
2023
Prepublished in Year
0
HGF-reported in Year
2023
ISSN (print) / ISBN
2076-3921
e-ISSN
2076-3921
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 12,
Issue: 2,
Pages: ,
Article Number: 22
Supplement: ,
Series
Publisher
MDPI
Publishing Place
St Alban-anlage 66, Ch-4052 Basel, Switzerland
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502600-005
Grants
Excellence Initiative by the German Federal and State Governments
German Centre for Cardiovascular Research (DZHK)
Deutsche Forschungsgemeinschaft (DFG)
Government of Ghana
German Academic Exchange Service (DAAD)
Copyright
Erfassungsdatum
2023-03-01